Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging.

[1]  S. Bigler,et al.  Prospective study of correlations between biopsy‐detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race , 2001, Cancer.

[2]  H A Guess,et al.  Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection. , 2000, JAMA.

[3]  H. Parnes,et al.  Prostate cancer prevention trials in the USA. , 2000, European journal of cancer.

[4]  B. Ponder,et al.  Familial predisposition to breast cancer in a British population: implications for prevention. , 2000, European journal of cancer.

[5]  O. Bratt.  Hereditary prostate cancer , 2000, BJU international.

[6]  P. Walsh,et al.  Cancer surveillance series: interpreting trends in prostate cancer--part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. , 2000, The Journal of urology.

[7]  I. Bairati,et al.  Downward trend in prostate cancer mortality in Quebec and Canada. , 1999, The Journal of urology.

[8]  E. Bergstralh,et al.  Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota. , 1999, The Journal of urology.

[9]  D. S. Coffey,et al.  Stem cell features of benign and malignant prostate epithelial cells. , 1998, The Journal of urology.

[10]  G. Murphy,et al.  American Cancer Society guidelines for the early detection of prostate cancer , 1997, Cancer.

[11]  J. Moul,et al.  Age-specific reference ranges for serum prostate-specific antigen in black men. , 1996, The New England journal of medicine.

[12]  M. Stampfer,et al.  A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. , 1995, JAMA.

[13]  T. Beaty,et al.  Hereditary prostate cancer: epidemiologic and clinical features. , 1993, The Journal of urology.

[14]  C G Chute,et al.  Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. , 1993, JAMA.

[15]  E. Metter,et al.  Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. , 1992, JAMA.